In this new white paper, Dr. Ronald Danis, MERIT’s CSO, examines how OCT-based structural endpoints, including ellipsoid zone attenuation, choroidal hypertransmission defects, and MERIT's outer retina-choroid (ORC™) imaging approach, are reshaping endpoint strategy for dry AMD trials....
This white paper examines why the outer retina-choroid (ORC™) en face optical coherence tomography (OCT) image may offer advantages over the fundus autofluorescence (FAF) image as a structural endpoint for dry age-related macular degeneration (AMD) clinical trials, with particular relevance to designs that pair structural...
Learn more about how to mitigate risk and choose your Imaging CRO correctly the first time....
Our template provides a standardized, weighted scoring framework for evaluating imaging CRO vendors....
Learn about disease states, viral and non-viral vectors, routes of delivery, specialized endpoints, and future directions for gene therapy in the treatment of IRDs....
Learn how UWF imaging contributes to understanding pathology in the peripheral retina (particularly with diabetic retinopathy), about current UWF imaging systems, and potential future innovations....
In this white paper you will learn four potential issues presented in MBPCs and how you can solve for these with MERIT....
Discover six challenges presented by clinical trial OCTs and how you can solve for these with MERIT....